Five additional EU member states -- Belgium, Denmark, Estonia, Finland and Latvia -- have been confirmed by the FDA as capable of performing drug and active pharmaceutical ingredient Good Manufacturing Practice inspections at a level equivalent to that of the agency. The FDA will be able to rely on 20 EU member states for GMP inspections.

Full Story:

Related Summaries